Gerresheimer AG (ETR:GXI)
18.99
+0.87 (4.80%)
At close: Mar 6, 2026
Gerresheimer AG Market Cap
Gerresheimer AG has a market cap or net worth of €655.91 million as of March 6, 2026. Its market cap has decreased by -76.58% in one year.
Market Cap
655.91M
Enterprise Value
2.85B
Revenue
2.25B
Ranking
n/a
PE Ratio
28.09
Stock Price
€18.99
Market Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has decreased from 1.20B to 655.91M, a decrease of -45.53%. That is a compound annual growth rate of -3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 655.91M | -31.15% |
| Dec 30, 2025 | 952.61M | -61.15% |
| Dec 30, 2024 | 2.45B | -24.75% |
| Dec 29, 2023 | 3.26B | 65.26% |
| Dec 30, 2022 | 1.97B | -25.86% |
| Dec 30, 2021 | 2.66B | -3.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 47.89B |
| Siemens Healthineers AG | 45.09B |
| Bayer Aktiengesellschaft | 35.75B |
| Fresenius SE & Co. KGaA | 26.32B |
| Evotec SE | 957.90M |
| Eckert & Ziegler SE | 947.37M |
| RHÖN-KLINIKUM Aktiengesellschaft | 856.81M |
| Redcare Pharmacy NV | 846.29M |